BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 17
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (8679)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-7) series.
Item 
Count 
PDF919
HTML7350
Figures (1-5)195
Tables (1-7)215
 Sum=8679
May 7, 2008 (publication date) through Jul 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14(17): 2650-2661 [PMID: 18461650 DOI: 10.3748/wjg.14.2650]
URL: https://www.wjgnet.com/1007-9327/full/v14/i17/2650.htm
Number Citing Articles
1
Azadeh Tavakoli, Judith Louise Flanagan. The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics?. Antibiotics 2019; 8(3): 88 doi: 10.3390/antibiotics8030088
2
Eamonn M.M. Quigley. Probiotics in the Management of Functional Bowel Disorders. Gastroenterology Clinics of North America 2012; 41(4): 805 doi: 10.1016/j.gtc.2012.08.005
3
Lynne Vernice McFarland, Tarkan Karatas, Ali Karatas. Strain-Specific and Outcome-Specific Efficacy of Probiotics for the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3894914
4
Hafiza Maryam Yasmin, Tahir Zahoor, Ambreen Sagheer, Muhammad Nadeem, Adnan Khaliq, Rabia Iqbal, Samreen Ahsan, Zulfiqar Ahmad. Assessment of antagonistic activity of free and encapsulated Bifidobacterium bifidum against Salmonella. Journal of Food Safety 2018; 38(6) doi: 10.1111/jfs.12546
5
Viola Andresen, Jutta Keller, Christian Pehl, Michael Schemann, Jan Preiss, Peter Layer. Irritable Bowel Syndrome. Deutsches Ärzteblatt international 2011;  doi: 10.3238/arztebl.2011.0751
6
Donald N. Tsynman, Savanna Thor, Joyann A. Kroser. Treatment of Irritable Bowel Syndrome in Women. Gastroenterology Clinics of North America 2011; 40(2): 265 doi: 10.1016/j.gtc.2011.03.012
7
Fergus Shanahan, Eamonn M.M. Quigley. Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies. Gastroenterology 2014; 146(6): 1554 doi: 10.1053/j.gastro.2014.01.050
8
G. C. Parkes, J. D. Sanderson, K. Whelan. Treating irritable bowel syndrome with probiotics: the evidence. Proceedings of the Nutrition Society 2010; 69(2): 187 doi: 10.1017/S002966511000011X
9
Richard A. Schatz, Baharak Moshiree. Gastrointestinal and Hepatic Disease in Fibromyalgia. Rheumatic Disease Clinics of North America 2018; 44(1): 131 doi: 10.1016/j.rdc.2017.09.009
10
Marwa M. El-Dalatony, Mostafa El-Sheekh, Xiangkai Li. Gut Remediation of Environmental Pollutants. 2020; : 169 doi: 10.1007/978-981-15-4759-1_6
11
Carmelo Scarpignato, Anna Bertelé, Antonio Tursi. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1): S70 doi: 10.1097/MCG.0000000000000641
12
Mohammad Mehdi Ommati, Huifeng Li, Akram Jamshidzadeh, Fereshteh Khoshghadam, Socorro Retana-Márquez, Yu Lu, Omid Farshad, Mohammad Hasan Nategh Ahmadi, Ahmad Gholami, Reza Heidari. The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(2): 247 doi: 10.1007/s00210-021-02177-0
13
L. V. McFarland. From Yaks to Yogurt: The History, Development, and Current Use of Probiotics. Clinical Infectious Diseases 2015; 60(suppl 2): S85 doi: 10.1093/cid/civ054
14
Félix Millán Rodríguez, Laia Sabiote Rubio, Irene Girón Nanne, Francisco Sánchez Martín, Esteban Emiliani, Oriol Angerri Feu. The relationship between calcium oxalate lithiasis and chronic proinflammatory intestinal dysbiosis pattern: a prospective study. Urolithiasis 2020; 48(4): 321 doi: 10.1007/s00240-020-01181-y
15
Mitchell L Jones, Christopher J Martoni, Jorge G Ganopolsky, Imran Sulemankhil, Peter Ghali, Satya Prakash. Improvement of gastrointestinal health status in subjects consumingLactobacillus reuteriNCIMB 30242 capsules: apost-hocanalysis of a randomized controlled trial. Expert Opinion on Biological Therapy 2013; 13(12): 1643 doi: 10.1517/14712598.2013.833601
16
Ulrike Voß, Anne Lewerenz, Karen Nieber. Sex and Gender Differences in Pharmacology. Handbook of Experimental Pharmacology 2013; 214: 473 doi: 10.1007/978-3-642-30726-3_21
17
Eamonn M. M. Quigley, Fergus Shanahan. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. Advances in Experimental Medicine and Biology 2014; 817: 417 doi: 10.1007/978-1-4939-0897-4_19
18
Bian Tiequn, Chao Guanqun, Zhang Shuo. Therapeutic Effects of Lactobacillus in Treating Irritable Bowel Syndrome: A Meta-analysis. Internal Medicine 2015; 54(3): 243 doi: 10.2169/internalmedicine.54.2710
19
Marika Mikelsaar, Veronica Lazar, Andrew Onderdonk, Gilanfranco Donelli. Do probiotic preparations for humans really have efficacy?. Microbial Ecology in Health and Disease 2011; 22(1): 10128 doi: 10.3402/mehd.v22i0.10128
20
Ritu Dahiya, Harpal S. Buttar, Suresh K. Gupta. Handbook of Nutraceuticals and Natural Products. 2022; : 397 doi: 10.1002/9781119746843.ch30
21
Duane Charbonneau, Roger D. Gibb, Eamonn M.M. Quigley. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013; 4(3): 201 doi: 10.4161/gmic.24196
22
Elisa Bertazzoni, Gianfranco Donelli, Tore Midtvedt, Jacques Nicoli, Yolanda Sanz. Probiotics and clinical effects: is the number what counts?. Journal of Chemotherapy 2013; 25(4): 193 doi: 10.1179/1973947813Y.0000000078
23
Luis Fontana, Miriam Bermudez-Brito, Julio Plaza-Diaz, Sergio Muñoz-Quezada, Angel Gil. Sources, isolation, characterisation and evaluation of probiotics. British Journal of Nutrition 2013; 109(S2): S35 doi: 10.1017/S0007114512004011
24
Cheryl Stevenson, Renée Blaauw, Ernst Fredericks, Janicke Visser, Saartjie Roux. Probiotic effect and dietary correlations on faecal microbiota profiles in irritable bowel syndrome. South African Journal of Clinical Nutrition 2021; 34(3): 84 doi: 10.1080/16070658.2019.1697038
25
Perry Hookman, Jamie S Barkin. <italic>Clostridium difficile</italic> associated infection, diarrhea and colitis. World Journal of Gastroenterology 2009; 15(13): 1554-1580 doi: 10.3748/wjg.15.1554
26
Hania Szajewska. Probiotics and Health Claims. 2011; : 149 doi: 10.1002/9781444329384.ch11
27
Eamonn MM Quigley. Prebiotics for irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2009; 3(5): 487 doi: 10.1586/egh.09.46
28
Beth Wallace. Clinical Use of Probiotics in the Pediatric Population. Nutrition in Clinical Practice 2009; 24(1): 50 doi: 10.1177/0884533608329298
29
Heiner Krammer, Markus Bluhm. Probiotika bei Reizdarmsyndrom. Pharmazie in unserer Zeit 2012; 41(2): 134 doi: 10.1002/pauz.201100461
30
Loveleen Kaur Sarao, M. Arora. Probiotics, prebiotics, and microencapsulation: A review. Critical Reviews in Food Science and Nutrition 2017; 57(2): 344 doi: 10.1080/10408398.2014.887055
31
Catherine Ulbricht, Tantri Budiman, Wendy Chao, Shaina Tanguay-Colucci, Julie Conquer, Dawn Costa, Richard Isaac, Joseph Parriott, Amarita Randhawa, Erica Rusie, Jill M. Grimes Serrano, Minney Varghese, Jen Woods, Sara Zhou. Probiotics (Bifidobacterium, Lactobacillus, and Saccharomyces boulardii): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration. Alternative and Complementary Therapies 2011; 17(6): 334 doi: 10.1089/act.2011.17601
32
I. W. Fong. The Role of Microbes in Common Non-Infectious Diseases. 2014; : 1 doi: 10.1007/978-1-4939-1670-2_1
33
Jumana Abuqwider, Mohammad Altamimi, Gianluigi Mauriello. Limosilactobacillus reuteri in Health and Disease. Microorganisms 2022; 10(3): 522 doi: 10.3390/microorganisms10030522
34
Hanneke Bles, Arie Knuistingh Neven. Probiotica bij irritable bowel syndrome. Huisarts en wetenschap 2011; 54(6): 346 doi: 10.1007/s12445-011-0168-y
35
Ji Hye Jeong, Soojin Jang, Bong Jun Jung, Kyung-Soon Jang, Byung-Gee Kim, Dae Kyun Chung, Hangeun Kim. Differential immune-stimulatory effects of LTAs from different lactic acid bacteria via MAPK signaling pathway in RAW 264.7 cells. Immunobiology 2015; 220(4): 460 doi: 10.1016/j.imbio.2014.11.002
36
Charlotte Pratt, Matthew D. Campbell. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Probiotics and Antimicrobial Proteins 2020; 12(3): 834 doi: 10.1007/s12602-019-09609-7
37
Juan José Sebastián Domingo. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017; 40(6): 417 doi: 10.1016/j.gastre.2016.12.001
38
Am&eacute;lie Cayzeele-Decherf, Fanny P&eacute;lerin, S&eacute;bastien Leuillet, Benoit Douillard, B&eacute;atrice Housez, Murielle Cazaubiel, Gunnard K Jacobson, Peter J&uuml;sten, Pierre Desreumaux. <i>Saccharomyces cerevisiae</i> CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World Journal of Gastroenterology 2017; 23(2): 336-344 doi: 10.3748/wjg.v23.i2.336
39
C. Stevenson, R. Blaauw, E. Fredericks, J. Visser, S. Roux. Food avoidance in irritable bowel syndrome leads to a nutrition-deficient diet. South African Journal of Clinical Nutrition 2014; 27(1): 25 doi: 10.1080/16070658.2014.11734481
40
John E. Morley. Probiotics and the Nursing Home: Should We Give Bacteria for Breakfast?. Journal of the American Medical Directors Association 2009; 10(6): 365 doi: 10.1016/j.jamda.2009.04.009
41
Mikihiro Fujiya, Yutaka Kohgo. Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions. Clinical Journal of Gastroenterology 2010; 3(3): 117 doi: 10.1007/s12328-010-0154-0
42
Rodrigo Vázquez-Frias, Alejandra Consuelo-Sánchez, Carlos Patricio Acosta-Rodríguez-Bueno, Andrés Blanco-Montero, Daniel Casas Robles, Vanessa Cohen, Daniel Márquez, Marcos Perez. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Pediatric Drugs 2023; 25(1): 115 doi: 10.1007/s40272-022-00536-9
43
Eamonn M. M. Quigley. Prebiotics and Probiotics. Nutrition in Clinical Practice 2012; 27(2): 195 doi: 10.1177/0884533611423926
44
P. Ducrotté. Ballonnement abdominal : où en est-on ?. Gastroentérologie Clinique et Biologique 2009; 33(10-11): F94 doi: 10.1016/j.gcb.2009.08.004
45
Xing Wang Gao, Mohamed Mubasher, Chong Yu Fang, Cheryl Reifer, Larry E Miller. Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile -Associated Diarrhea Prophylaxis in Adult Patients. American Journal of Gastroenterology 2010; 105(7): 1636 doi: 10.1038/ajg.2010.11
46
Nicole Bozzi Cionci, Marta Reggio, Loredana Baffoni, Diana Di Gioia. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 219 doi: 10.1007/978-3-031-19564-8_8
47
Nicola Principi, Rita Cozzali, Edoardo Farinelli, Andrea Brusaferro, Susanna Esposito. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Journal of Infection 2018; 76(2): 111 doi: 10.1016/j.jinf.2017.12.013
48
C Stevenson, R Blaauw. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 2011; 24(2): 63 doi: 10.1080/16070658.2011.11734353
49
Eleonora Giannetti, Marco Maglione, Annalisa Alessandrella, Caterina Strisciuglio, Donatella De Giovanni, Angelo Campanozzi, Erasmo Miele, Annamaria Staiano. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2017; 51(1): e5 doi: 10.1097/MCG.0000000000000528
50
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. 2022; : 217 doi: 10.2174/9789815051780122010009
51
Ibrahim Elmadfa, Petra Klein, Alexa L. Meyer. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proceedings of the Nutrition Society 2010; 69(3): 416 doi: 10.1017/S0029665110001710
52
Pratima Dibba, Megha Kothari, Irwin Grosman. Nutrition, Weight, and Digestive Health. 2022; : 169 doi: 10.1007/978-3-030-94953-2_11
53
Stephen M. Collins. A role for the gut microbiota in IBS. Nature Reviews Gastroenterology & Hepatology 2014; 11(8): 497 doi: 10.1038/nrgastro.2014.40
54
I. Qureshi, J.R. Endres. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 215 doi: 10.1016/B978-0-12-397154-8.00027-0
55
Oliver Grundmann, Saunjoo L Yoon. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health‐care practitioners. Journal of Gastroenterology and Hepatology 2010; 25(4): 691 doi: 10.1111/j.1440-1746.2009.06120.x
56
Peter Henningsen, Stephan Zipfel, Heribert Sattel, Francis Creed. Management of Functional Somatic Syndromes and Bodily Distress. Psychotherapy and Psychosomatics 2018; 87(1): 12 doi: 10.1159/000484413
57
Emmeline Edwards, D. Lee Alekel, Barbara Stussman. Women and Health. 2013; : 57 doi: 10.1016/B978-0-12-384978-6.00005-4
58
Ashraf MORCOS, Ted DINAN, Eamonn MM QUIGLEY. Irritable bowel syndrome: Role of food in pathogenesis and management. Journal of Digestive Diseases 2009; 10(4): 237 doi: 10.1111/j.1751-2980.2009.00392.x
59
H. Krammer, M. Bluhm, B. Niesler. Reizdarmsyndrom. CME 2012; 9(12): 41 doi: 10.1007/s11298-012-1705-0
60
Hale Akpınar. Probiotics and Prebiotics in Food, Nutrition and Health. 2013; : 308 doi: 10.1201/b15561-16
61
A. N. Suvorov. Microbial personified therapy as an instrument of medical doctor in the future. Russian Journal for Personalized Medicine 2022; 2(1): 51 doi: 10.18705/2782-3806-2022-2-1-51-62
62
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner. Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 2014; 20(27): 8796 doi: 10.3748/wjg.v20.i27.5796
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
63
Marta Caretto, Andrea Giannini, Eleonora Russo, Paolo Mannella, Tommaso Simoncini. Pre-Menopause, Menopause and Beyond. ISGE Series 2018; : 303 doi: 10.1007/978-3-319-63540-8_27
64
Anat Hershko-Moshe, Yaako’v Hasin, Anat Nevo-Shor, Ohad Etzion, Yaron Ilan, Soe Thiha Maung. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022; 2022: 1 doi: 10.1155/2022/1192547
65
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2023; : 729 doi: 10.1007/978-3-031-14744-9_52
66
Silvia Salvatore, Yvan Vandenplas. Bioactive Foods in Promoting Health. 2010; : 181 doi: 10.1016/B978-0-12-374938-3.00013-X
67
Maneesh Dave, Peter D. Higgins, Sumit Middha, Kevin P. Rioux. The human gut microbiome: current knowledge, challenges, and future directions. Translational Research 2012; 160(4): 246 doi: 10.1016/j.trsl.2012.05.003
68
Naire Sansotta, Diego G. Peroni, Simone Romano, Anna Rugiano, Pierluigi Vuilleumier, Giuseppe Baviera. The good bugs: the use of probiotics in pediatrics. Current Opinion in Pediatrics 2019; 31(5): 661 doi: 10.1097/MOP.0000000000000808
69
Mary Ellen Sanders, Maria L. Marco. Food Formats for Effective Delivery of Probiotics. Annual Review of Food Science and Technology 2010; 1(1): 65 doi: 10.1146/annurev.food.080708.100743
70
Motoyori Kanazawa, Shin Fukudo. Relationship between infectious gastroenteritis and irritable bowel syndrome. Clinical Journal of Gastroenterology 2014; 7(1): 14 doi: 10.1007/s12328-013-0444-4
71
Robin Spiller, Fanny Pélerin, Amélie Cayzeele Decherf, Corinne Maudet, Béatrice Housez, Murielle Cazaubiel, Peter Jüsten. Randomized double blind placebo-controlled trial ofSaccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterology Journal 2016; 4(3): 353 doi: 10.1177/2050640615602571
72
Xiangping Wang, Yikuan Feng, Jiansheng Li, Zibin Tian, Dong Wei, Lingzhi Qi, Lifeng Fang, Kaichun Wu. Routine clinical administration of 4-week alverine citrate and simeticone combination relief global IBS symptoms. Open Journal of Gastroenterology 2014; 4(01): 32 doi: 10.4236/ojgas.2014.41006
73
Jiayue Gu, Ke Song, Yixuan Fan, Yao Dong, Limin Qian, Zhonghui Gai. Safety evaluation of Bifidobacterium animalis subsp. lactis BLa80 under in vitro, and in vivo conditions. Microbial Pathogenesis 2024; 194: 106809 doi: 10.1016/j.micpath.2024.106809
74
Marina L. Ritchie, Tamara N. Romanuk, Markus M. Heimesaat. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS ONE 2012; 7(4): e34938 doi: 10.1371/journal.pone.0034938
75
Gerard E. Mullin, Sue J. Shepherd, Bani Chander Roland, Carol Ireton‐Jones, Laura E. Matarese. Irritable Bowel Syndrome. Journal of Parenteral and Enteral Nutrition 2014; 38(7): 781 doi: 10.1177/0148607114545329
76
Dirk Haller, Jean-Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir-Wijnkoop. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3. The Journal of Nutrition 2010; 140(3): 690S doi: 10.3945/jn.109.113746
77
Huan Wang, Jing Gong, Wenfeng Wang, Yanqin Long, Xiaochao Fu, Yu Fu, Wei Qian, Xiaohua Hou, Michael Koval. Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?. PLoS ONE 2014; 9(3): e90153 doi: 10.1371/journal.pone.0090153
78
Paul J. Kennedy, Gerard Clarke, Eamonn M.M. Quigley, John A. Groeger, Timothy G. Dinan, John F. Cryan. Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome. Neuroscience & Biobehavioral Reviews 2012; 36(1): 310 doi: 10.1016/j.neubiorev.2011.07.001
79
Christina L. Ohland, Wallace K. MacNaughton. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 298(6): G807 doi: 10.1152/ajpgi.00243.2009
80
Marguerite Klein, Mary Ellen Sanders, Tri Duong, Howard A. Young. Probiotics: From Bench to Market. Annals of the New York Academy of Sciences 2010; 1212(s1) doi: 10.1111/j.1749-6632.2010.05839.x
81
Silvia Pisaneschi, Giulia Palla, Stefania Spina, Guja Bernacchi, Elena Cecchi, Silvia Di Bello, Magdalena Montt Guevara, Adrian Campelo, Tommaso Simoncini. Frontiers in Gynecological Endocrinology. ISGE Series 2014; : 215 doi: 10.1007/978-3-319-03494-2_21
82
Magnus Halland, Nicholas J. Talley. New treatments for IBS. Nature Reviews Gastroenterology & Hepatology 2013; 10(1): 13 doi: 10.1038/nrgastro.2012.207
83
C. H. Choi, J. G. Kwon, S. K. Kim, S.‐J. Myung, K. S. Park, C.‐I. Sohn, P.‐L. Rhee, K. J. Lee, O. Y. Lee, H.‐K. Jung, S. R. Jee, Y. T. Jeen, M.‐G. Choi, S. C. Choi, K. C. Huh, H. Park. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial. Neurogastroenterology & Motility 2015; 27(5): 705 doi: 10.1111/nmo.12544
84
Lynne V. McFarland. Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity. Digestive Diseases and Sciences 2021; 66(3): 694 doi: 10.1007/s10620-020-06244-z
85
Sang-Hoon Lee, Doo-Yeoun Cho, Seok-Hoon Lee, Kyung-Sun Han, Sung-Won Yang, Jin-Ho Kim, Su-Hyun Lee, Soo-Min Kim, Kyu-Nam Kim. A Randomized Clinical Trial of Synbiotics in Irritable Bowel Syndrome: Dose-Dependent Effects on Gastrointestinal Symptoms and Fatigue. Korean Journal of Family Medicine 2019; 40(1): 2 doi: 10.4082/kjfm.17.0064
86
Satish Ramraj, Arul Venkatesan. Nutraceuticals and Functional Foods in Human Health and Disease Prevention. 2015; : 629 doi: 10.1201/b19308-55
87
P. Ducrotté. Post’U FMC-HGE. 2010; : 89 doi: 10.1007/978-2-8178-0097-4_11
88
Gerard E. Mullin. Probiotics and Digestive Disease. Nutrition in Clinical Practice 2012; 27(2): 300 doi: 10.1177/0884533612439609
89
A. Horvath, P. Dziechciarz, H. Szajewska. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Alimentary Pharmacology & Therapeutics 2011; 33(12): 1302 doi: 10.1111/j.1365-2036.2011.04665.x
90
Abeer Ahmed Rushdy, Eman Zakaria Gomaa. Antimicrobial compounds produced by probiotic Lactobacillus brevis isolated from dairy products. Annals of Microbiology 2013; 63(1): 81 doi: 10.1007/s13213-012-0447-2
91
J. König, R.J. Brummer. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014; 5(3): 247 doi: 10.3920/BM2013.0033
92
Amir Mari, Fadi Abu Baker, Mahmud Mahamid, Wisam Sbeit, Tawfik Khoury. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. Journal of Clinical Medicine 2020; 9(3): 685 doi: 10.3390/jcm9030685
93
Eamonn M. M. Quigley. Probiotics and Irritable Bowel Syndrome. Bioscience and Microflora 2009; 28(4): 119 doi: 10.12938/bifidus.28.119
94
Oleg Jadrešin, Iva Hojsak, Zrinjka Mišak, Alemka Jaklin Kekez, Tena Trbojević, Lana Ivković, Sanja Kolaček. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(6): 925 doi: 10.1097/MPG.0000000000001478
95
Yehuda Ringel, Tamar Ringel-Kulka. The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2011; 45: S145 doi: 10.1097/MCG.0b013e31822d32d3
96
Frederick Odun-Ayo, Lalini Reddy. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics. Gastroenterology Insights 2022; 13(1): 35 doi: 10.3390/gastroent13010006
97
Michael Camilleri, Emeran A. Mayer. Developing Irritable Bowel Syndrome Guidelines Through Meta-analyses: Does the Emperor Really Have New Clothes?. Gastroenterology 2009; 137(3): 766 doi: 10.1053/j.gastro.2009.07.030
98
L.V. McFarland. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 145 doi: 10.1016/B978-0-12-804024-9.00018-5
99
Charles M.A.P. Franz, Melanie Huch, Hikmate Abriouel, Wilhelm Holzapfel, Antonio Gálvez. Enterococci as probiotics and their implications in food safety. International Journal of Food Microbiology 2011; 151(2): 125 doi: 10.1016/j.ijfoodmicro.2011.08.014
100
Alenka Šmid, Luka Strniša, Katarina Bajc, Dunja Vujić-Podlipec, Bojana Bogovič Matijašić, Irena Rogelj. Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults. Journal of Functional Foods 2016; 24: 549 doi: 10.1016/j.jff.2016.04.031
101
N. Saad, C. Delattre, M. Urdaci, J.M. Schmitter, P. Bressollier. An overview of the last advances in probiotic and prebiotic field. LWT - Food Science and Technology 2013; 50(1): 1 doi: 10.1016/j.lwt.2012.05.014
102
Suma S Magge, Jacqueline L Wolf. Complementary and Alternative Medicine and Mind–Body Therapies for Treatment of Irritable Bowel Syndrome in Women. Women's Health 2013; 9(6): 557 doi: 10.2217/WHE.13.57
103
Larysa Hun. Original Research:Bacillus coagulansSignificantly Improved Abdominal Pain and Bloating in Patients with IBS. Postgraduate Medicine 2009; 121(2): 119 doi: 10.3810/pgm.2009.03.1984
104
Verena Grimm, Christian U. Riedel. Microbiota of the Human Body. Advances in Experimental Medicine and Biology 2016; 902: 109 doi: 10.1007/978-3-319-31248-4_8
105
Akira Andoh, Takehide Fujimoto, Kenichiro Takahashi. Association between the Gut Microbiota and Intestinal Disorders. Nihon Naika Gakkai Zasshi 2013; 102(11): 2983 doi: 10.2169/naika.102.2983
106
M. Lunder. Dietary Supplements. 2015; : 171 doi: 10.1533/9781782420811.3.171
107
Lynne V McFarland. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World Journal of Gastroenterology 2008; 14(17): 2625-2629 doi: 10.3748/wjg.14.2625
108
William D. Heizer, Susannah Southern, Susan McGovern. The Role of Diet in Symptoms of Irritable Bowel Syndrome in Adults: A Narrative Review. Journal of the American Dietetic Association 2009; 109(7): 1204 doi: 10.1016/j.jada.2009.04.012
109
W. Allan Walker, Kasey Heintz. Protective Nutrients. Nutrition Today 2012; 47(3): 110 doi: 10.1097/NT.0b013e318257b85c
110
Oscar Brunser, Javier Bravo, Martin Gotteland. Probiotics and Prebiotics in Food, Nutrition and Health. 2013; : 464 doi: 10.1201/b15561-24
111
Aaron J. Michelfelder, Kit C. Lee, Eva M. Bading. Integrative Medicine and Gastrointestinal Disease. Primary Care: Clinics in Office Practice 2010; 37(2): 255 doi: 10.1016/j.pop.2010.02.003
112
G. Sisson, S. Ayis, R. A. Sherwood, I. Bjarnason. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study. Alimentary Pharmacology & Therapeutics 2014; 40(1): 51 doi: 10.1111/apt.12787
113
Ji-Seon Ahn, Yu-Jin Choi, Han-Byeol Kim, Hea-Jong Chung, Seong-Tshool Hong. Identification of the Intestinal Microbes Associated with Locomotion. International Journal of Molecular Sciences 2023; 24(14): 11392 doi: 10.3390/ijms241411392
114
Dirk Haller, Gabriele Hörmannsperger. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013; : 67 doi: 10.1007/978-3-642-29374-0_6
115
D. I. Trukhan, V. V. Goloshubina, D. S. Ivanova. Actual issues of diagnosis and treatment of irritable bowel syndrome. Medical Council 2019; (21): 110 doi: 10.21518/2079-701X-2018-21-110-116
116
Tahreem Riaz, Muhammad Waheed Iqbal, Muhammad Saeed, Iqra Yasmin, Hinawi A. M. Hassanin, Shahid Mahmood, Abdur Rehman. In vitro survival of Bifidobacterium bifidum microencapsulated in zein-coated alginate hydrogel microbeads. Journal of Microencapsulation 2019; 36(2): 192 doi: 10.1080/02652048.2019.1618403
117
Gareth C. Parkes. Bioactive Foods in Promoting Health. 2010; : 513 doi: 10.1016/B978-0-12-374938-3.00030-X
118
Ya-Nan Cao, Li-Juan Feng, Yuan-Yuan Liu, Kui Jiang, Mao-Jun Zhang, Yi-Xin Gu, Bang-Mao Wang, Jia Gao, Ze-Lan Wang, Yu-Ming Wang. Effect of <i>Lactobacillus rhamnosus</i> GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome. World Journal of Gastroenterology 2018; 24(3): 338-350 doi: 10.3748/wjg.v24.i3.338
119
Y. A. McKenzie, J. Thompson, P. Gulia, M. C. E. Lomer. British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5): 576 doi: 10.1111/jhn.12386
120
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
121
Paul Enck, Florian Junne, Sibylle Klosterhalfen, Stephan Zipfel, Ute Martens. Therapy options in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2010; : 1 doi: 10.1097/MEG.0b013e3283405a17
122
Kevin Whelan, Eamonn M.M. Quigley. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Current Opinion in Gastroenterology 2013; 29(2): 184 doi: 10.1097/MOG.0b013e32835d7bba
123
Elizabeth J. Videlock, Lin Chang. Yamada' s Textbook of Gastroenterology. 2015; : 1495 doi: 10.1002/9781118512074.ch75
124
S. Liptay, S. Burdach. Probiotika bei Kindern und Jugendlichen mit Darmerkrankung. Monatsschrift Kinderheilkunde 2008; 156(11): 1076 doi: 10.1007/s00112-008-1831-7
125
Hamed Ebrahimzadeh Leylabadlo, Fatemah Sadeghpour Heravi, Elghar Soltani, Amin Abbasi, Hossein Samadi Kafil, Mahdi Parsaei, Sarvin Sanaie, Zainab Ahmadian, Reza Ghotaslou. The role of gut microbiota in the treatment of irritable bowel syndrome. Reviews in Medical Microbiology 2022; 33(1): e89 doi: 10.1097/MRM.0000000000000284
126
Magnus Simrén. Review: Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?. Therapeutic Advances in Gastroenterology 2009; 2(4_suppl): S5 doi: 10.1177/1756283X09337569
127
Reizdarmsyndrom wird immer besser verstanden. MMW - Fortschritte der Medizin 2014; 156(19): 60 doi: 10.1007/s15006-014-3643-0
128
H. Krammer, M. Bluhm, B. Niesler. Reizdarmsyndrom. coloproctology 2012; 34(2): 157 doi: 10.1007/s00053-011-0218-8
129
A.R. Bhat, V.U. Irorere, T. Bartlett, D. Hill, G. Kedia, D. Charalampopoulos, S. Nualkaekul, I. Radecka. Improving survival of probiotic bacteria using bacterial poly-γ-glutamic acid. International Journal of Food Microbiology 2015; 196: 24 doi: 10.1016/j.ijfoodmicro.2014.11.031
130
Geoffrey A. Preidis, James Versalovic. Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era. Gastroenterology 2009; 136(6): 2015 doi: 10.1053/j.gastro.2009.01.072
131
O. F. Ahmad, A. Akbar. Dietary treatment of irritable bowel syndrome. British Medical Bulletin 2015; 113(1): 83 doi: 10.1093/bmb/ldu039
132
Luise Mølenberg Begtrup, Ove B Schaffalitzky de Muckadell, Jens Kjeldsen, René dePont Christensen, Dorte Ejg Jarbøl. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 2013; 48(10): 1127 doi: 10.3109/00365521.2013.825314
133
S. Guandalini, E. Cernat, D. Moscoso. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Beneficial Microbes 2015; 6(2): 209 doi: 10.3920/BM2014.0067
134
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterología. Revista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
135
Shenghui Zhou, Xiaoli Liu, Xiaoxia Wang, Fenglin Xi, Xiaoke Luo, Liang Yao, Hao Tang. Pharmacological and non-pharmacological treatments for irritable bowel syndrome. Medicine 2019; 98(30): e16446 doi: 10.1097/MD.0000000000016446
136
Dirk Haller, Gerald Rimbach, Tilman Grune. Biofunktionalität der Lebensmittelinhaltsstoffe. Springer-Lehrbuch 2013; : 281 doi: 10.1007/978-3-642-29374-0_21
137
Carlo M. Bergamini, Nicoletta Bianchi, Valerio Giaccone, Paolo Catellani, Leonardo Alberghini, Alessandra Stella, Stefano Biffani, Sachithra Kalhari Yaddehige, Tania Bobbo, Cristian Taccioli. Machine Learning Algorithms Highlight tRNA Information Content and Chargaff’s Second Parity Rule Score as Important Features in Discriminating Probiotics from Non-Probiotics. Biology 2022; 11(7): 1024 doi: 10.3390/biology11071024
138
Nazar Mazurak, Ellen Broelz, Martin Storr, Paul Enck. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?. Journal of Neurogastroenterology and Motility 2015; 21(4): 471 doi: 10.5056/jnm15071
139
Y. A. McKenzie, R. K. Bowyer, H. Leach, P. Gulia, J. Horobin, N. A. O'Sullivan, C. Pettitt, L. B. Reeves, L. Seamark, M. Williams, J. Thompson, M. C. E. Lomer. British Dietetic Association systematic review and evidence‐based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics 2016; 29(5): 549 doi: 10.1111/jhn.12385
140
Lynne V. McFarland, Tarkan Karakan, Ali Karatas. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. eClinicalMedicine 2021; 41: 101154 doi: 10.1016/j.eclinm.2021.101154
141
Linda V. Thomas, Kaori Suzuki, Jia Zhao. Probiotics: a proactive approach to health. A symposium report. British Journal of Nutrition 2015; 114(S1): S1 doi: 10.1017/S0007114515004043
142
P. Enck, K. Zimmermann, K. Rusch, A. Schwiertz, S. Klosterhalfen, J. S. Frick. The Effects of Maturation on the Colonic Microflora in Infancy and Childhood. Gastroenterology Research and Practice 2009; 2009: 1 doi: 10.1155/2009/752401
143
S. Shukla, A. Shukla, S. Mehboob, S. Guha. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 2011; 33(6): 662 doi: 10.1111/j.1365-2036.2010.04574.x
144
Randal Buddington. Prebiotics and Probiotics Science and Technology. 2009; : 1 doi: 10.1007/978-0-387-79058-9_1
145
Wojciech Marlicz, Diana E Yung, Karolina Skonieczna-Żydecka, Igor Loniewski, Saskia van Hemert, Beata Loniewska, Anastasios Koulaouzidis. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 961 doi: 10.1080/17474124.2017.1343664
146
Wolfgang Kruis, Sigrun Chrubasik, Stephan Boehm, Christiane Stange, Juergen Schulze. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. International Journal of Colorectal Disease 2012; 27(4): 467 doi: 10.1007/s00384-011-1363-9
147
Stefano Guandalini, Giuseppe Magazzù, Andrea Chiaro, Valeria La Balestra, Giovanni Di Nardo, Sarath Gopalan, A Sibal, Claudio Romano, Roberto Berni Canani, Paolo Lionetti, Mala Setty. VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo‐Controlled, Double‐Blind, Crossover Study. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(1): 24 doi: 10.1097/MPG.0b013e3181ca4d95
148
K. Hod, A. D. Sperber, Y. Ron, M. Boaz, R. Dickman, S. Berliner, Z. Halpern, N. Maharshak, R. Dekel. A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS. Neurogastroenterology & Motility 2017; 29(7) doi: 10.1111/nmo.13037
149
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2017; : 639 doi: 10.1007/978-3-319-49215-5_52
150
Khalil I. El-Chammas, Manu R. Sood. Pediatric Inflammatory Bowel Disease. 2013; : 505 doi: 10.1007/978-1-4614-5061-0_46
151
Anna Lyra, Lotta Krogius-Kurikka, Janne Nikkilä, Erja Malinen, Kajsa Kajander, Kyösti Kurikka, Riitta Korpela, Airi Palva. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-110
152
Elvina Parlindungan, Oliver A. H. Jones. Using metabolomics to understand stress responses in Lactic Acid Bacteria and their applications in the food industry. Metabolomics 2023; 19(12) doi: 10.1007/s11306-023-02062-2
153
Jee-Yon Lee, Sang-Hui Chu, Justin Y. Jeon, Mi-Kyung Lee, Ji-Hye Park, Duk-Chul Lee, Ji-Won Lee, Nam-Kyu Kim. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial. Digestive and Liver Disease 2014; 46(12): 1126 doi: 10.1016/j.dld.2014.09.004
154
Helen L. Mitchell, Peter J. Aggett, David P. Richardson, Julian D. Stowell. Food & health forum meeting: evidence-based nutrition. British Journal of Nutrition 2011; 105(2): 322 doi: 10.1017/S0007114510003296
155
H. L. DuPont. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 2014; 39(10): 1033 doi: 10.1111/apt.12728
156
Aziz Koleilat. Textbook of Clinical Pediatrics. 2012; : 1887 doi: 10.1007/978-3-642-02202-9_192
157
Riaz A. Agha, Christian F. Camm, Eric Edison, Dennis P. Orgill. The methodological quality of randomized controlled trials in plastic surgery needs improvement: A systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013; 66(4): 447 doi: 10.1016/j.bjps.2012.11.005
158
Eamonn M.M. Quigley. Probiotics in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2015; 49(Supplement 1): S60 doi: 10.1097/MCG.0000000000000348
159
Kevin Whelan. Probiotics and prebiotics in the management of irritable bowel syndrome. Current Opinion in Clinical Nutrition and Metabolic Care 2011; 14(6): 581 doi: 10.1097/MCO.0b013e32834b8082
160
Denis Guyonnet, Armelle Schlumberger, Leila Mhamdi, Stefan Jakob, Olivier Chassany. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. British Journal of Nutrition 2009; 102(11): 1654 doi: 10.1017/S0007114509990882
161
Riitta Korpela, Leena Niittynen. Probiotics and Irritable Bowel Syndrome. Microbial Ecology in Health & Disease 2012; 23(0) doi: 10.3402/mehd.v23i0.18573
162
Gerard Mullin. Gastrointestinal and Liver Disease Nutrition Desk Reference. 2011; : 21 doi: 10.1201/b11184-4
163
Joaquim Prado MORAES-FILHO, Eamonn M M QUIGLEY. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review. Arquivos de Gastroenterologia 2015; 52(4): 331 doi: 10.1590/S0004-28032015000400015
164
Uday C Ghoshal, Hyojin Park, Kok‐Ann Gwee. Bugs and irritable bowel syndrome: The good, the bad and the ugly. Journal of Gastroenterology and Hepatology 2010; 25(2): 244 doi: 10.1111/j.1440-1746.2009.06133.x
165
T. Yakabe, E.L. Moore, S. Yokota, H. Sui, Y. Nobuta, M. Fukao, H. Palmer, N. Yajima. Safety assessment of Lactobacillus brevis KB290 as a probiotic strain. Food and Chemical Toxicology 2009; 47(10): 2450 doi: 10.1016/j.fct.2009.07.001
166
E. Weichselbaum. Probiotics and health: a review of the evidence. Nutrition Bulletin 2009; 34(4): 340 doi: 10.1111/j.1467-3010.2009.01782.x
167
Sumel Ashique, Tuhin Mukherjee, Satyajit Mohanty, Ashish Garg, Neeraj Mishra, Monika Kaushik, Mithun Bhowmick, Bornika Chattaraj, Sourav Mohanto, Shriyansh Srivastava, Farzad Taghizadeh-Hesary. Blueberries in focus: Exploring the phytochemical potentials and therapeutic applications. Journal of Agriculture and Food Research 2024; 18: 101300 doi: 10.1016/j.jafr.2024.101300
168
Paolo Mannella, Giulia Palla, Massimo Bellini, Tommaso Simoncini. The female pelvic floor through midlife and aging. Maturitas 2013; 76(3): 230 doi: 10.1016/j.maturitas.2013.08.008
169
Daniel Villageliú, Mark Lyte, Palok Aich. Dopamine production in Enterococcus faecium: A microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential. PLOS ONE 2018; 13(11): e0207038 doi: 10.1371/journal.pone.0207038
170
Alexander SUVOROV. Gut Microbiota, Probiotics, and Human Health. Bioscience of Microbiota, Food and Health 2013; 32(3): 81 doi: 10.12938/bmfh.32.81
171
Julia-Stefanie Frick, Ingo B. Autenrieth. Between Pathogenicity and Commensalism. Current Topics in Microbiology and Immunology 2012; 358: 273 doi: 10.1007/82_2012_217
172
Fifi M. Reda, Azza Z. Refaie. Purification and characterization of pedioxanthin (carotenoid pigment) produced by Pediococcus pentosaceus N33 strain isolated from pickles . Food Biotechnology 2019; 33(3): 217 doi: 10.1080/08905436.2019.1617166
173
Xue Shang, Fen-Fen E, Kang-Le Guo, Yan-Fei Li, Hong-Lin Zhao, Yan Wang, Nan Chen, Tao Nian, Chao-Qun Yang, Ke-Hu Yang, Xiu-Xia Li. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Nutrients 2022; 14(12): 2482 doi: 10.3390/nu14122482
174
Hao ZHANG, Jing SUN, Qing-yu WANG, Yu-tong HE, Hui-yong GU, Hui-yuan GUO, Qing-bo DING, Jun-si YANG, Fa-zheng REN. Safety Assessment of Lactobacillus salivarius REN, a Probiotic Strain Isolated from Centenarian Feces. Food Science and Technology Research 2013; 19(6): 1037 doi: 10.3136/fstr.19.1037
175
M. de Greck, P. Layer, V. Andresen. Schmerztherapie beim Reizdarmsyndrom. Der Schmerz 2014; 28(3): 289 doi: 10.1007/s00482-014-1406-6
176
J.R. Endres, A. Clewell, K.A. Jade, T. Farber, J. Hauswirth, A.G. Schauss. Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 2009; 47(6): 1231 doi: 10.1016/j.fct.2009.02.018
177
Emeran A. Mayer, Tor Savidge, Robert J. Shulman. Brain–Gut Microbiome Interactions and Functional Bowel Disorders. Gastroenterology 2014; 146(6): 1500 doi: 10.1053/j.gastro.2014.02.037
178
Geoffrey C Wall, Ginelle A Bryant, Michelle M Bottenberg, Erik D Maki, Andrew R Miesner. Irritable bowel syndrome: A concise review of current treatment concepts. World Journal of Gastroenterology 2014; 20(27): 8796-8806 doi: 10.3748/wjg.v20.i27.8796
179
Asieh Hosseini, Shekoufeh Nikfar, Mohammad Abdollahi. Probiotics use to treat irritable bowel syndrome. Expert Opinion on Biological Therapy 2012; 12(10): 1323 doi: 10.1517/14712598.2012.707179
180
Nurzulaikha Abdullah, Yee Cheng Kueh, Garry Kuan, Mung Seong Wong, Fatan Hamamah Yahaya, Nor Aslina Abd Samat, Khairil Khuzaini Zulkifli, Yeong Yeh Lee. Development and validation of the Health Promoting Behaviour for Bloating (HPB-Bloat) scale. PeerJ 2021; 9: e11444 doi: 10.7717/peerj.11444
181
Chander Shekhar, Peter J Whorwell. Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 2009; 14(4): 673 doi: 10.1517/14728210903222279
182
K. Preston, R. Krumian, J. Hattner, D. de Montigny, M. Stewart, S. Gaddam. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. Beneficial Microbes 2018; 9(5): 697 doi: 10.3920/BM2017.0105
183
Sonia Michail, Harshavardhan Kenche. Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome. Probiotics and Antimicrobial Proteins 2011; 3(1): 1 doi: 10.1007/s12602-010-9059-y
184
Mark Pimentel, Christopher Chang. Inflammation and Microflora. Gastroenterology Clinics of North America 2011; 40(1): 69 doi: 10.1016/j.gtc.2010.12.010
185
Sadegh Sulaimany, Kajal Farahmandi, Aso Mafakheri. Computational prediction of new therapeutic effects of probiotics. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62796-4
186
Saif Ul Islam. Clinical Uses of Probiotics. Medicine 2016; 95(5): e2658 doi: 10.1097/MD.0000000000002658
187
Michael Camilleri, Carlo Di Lorenzo. Brain‐Gut Axis. Journal of Pediatric Gastroenterology and Nutrition 2012; 54(4): 446 doi: 10.1097/MPG.0b013e31823d34c3
188
B. Duncan. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 449 doi: 10.1016/B978-0-12-397154-8.00005-1
189
María Torres‑Chávez, Nora Torres‑Carrillo, Ana Moreal‑Lugo, Sandra Garnés‑Rancurello, Selvasankar Murugesan, Itzae Gutiérrez‑Hurtado, Jesús Beltrán‑Ramírez, Elena Sandoval‑Pinto, Norma Torres‑Carrillo. Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review). Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1675
190
Sonia Michail. Probiotics in Pediatric Medicine. 2009; : 131 doi: 10.1007/978-1-60327-289-6_10
191
Stefano Guandalini. Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00023
192
Q. Aziz, J. Doré, A. Emmanuel, F. Guarner, E. M. M. Quigley. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterology & Motility 2013; 25(1): 4 doi: 10.1111/nmo.12046
193
Thanitsara Rittiphairoj, Krit Pongpirul, Noel T. Mueller, Tianjing Li. Probiotics for glycemic control in patients with type 2 diabetes mellitus: protocol for a systematic review. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-1145-y
194
G. Malaguarnera, F. Leggio, M. Vacante, M. Motta, M. Giordano, A. Biondi, F. Basile, S. Mastrojeni, A. Mistretta, Mariano Malaguarnera, M.A. Toscano, M. Salmeri. Probiotics in the gastrointestinal diseases of the elderly. The Journal of nutrition, health and aging 2012; 16(4): 402 doi: 10.1007/s12603-011-0357-1
195
Dorit Vedel Ankersen, Petra Weimers, Mette Bennedsen, Anne Birgitte Haaber, Eva Lund Fjordside, Moritz Emanuel Beber, Christian Lieven, Sanaz Saboori, Nicolai Vad, Terje Rannem, Dorte Marker, Kristine Paridaens, Suzanne Frahm, Lisbeth Jensen, Malte Rosager Hansen, Johan Burisch, Pia Munkholm. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial. Journal of Medical Internet Research 2021; 23(12): e30291 doi: 10.2196/30291
196
Ami PATEL, Nihir SHAH. Potentials of probiotics in the treatment of food allergy - a review. Czech Journal of Food Sciences 2014; 32(3): 205 doi: 10.17221/200/2013-CJFS
197
T. Piche. Anomalies pariétales et de la flore au cours du syndrome de l’intestin irritable. Gastroentérologie Clinique et Biologique 2009; 33: S40 doi: 10.1016/S0399-8320(09)71524-6
198
Stefano Guandalini. The Potential for use of Probiotics in Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease. Current Pediatrics Reports 2014; 2(3): 235 doi: 10.1007/s40124-014-0050-z
199
Eamonn M.M. Quigley. Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies. Gastroenterology Clinics of North America 2011; 40(1): 207 doi: 10.1016/j.gtc.2010.12.009
200
Eamonn M. M. Quigley. Probiotics in Gastrointestinal Disorders. Hospital Practice 2010; 38(4): 122 doi: 10.3810/hp.2010.11.349
201
L. Foster, T. Tompkins, W. Dahl. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Beneficial Microbes 2011; 2(4): 319 doi: 10.3920/BM2011.0032
202
Annalisa Passariello, Pascal Agricole, Peter Malfertheiner. A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Current Medical Research and Opinion 2014; 30(6): 1055 doi: 10.1185/03007995.2014.898138
203
Yi-Heng Chiu, Ying-Chen Lu, Chu-Chyn Ou, Shiao-Lin Lin, Chin-Chi Tsai, Chien-Tsai Huang, Meei-Yn Lin. Lactobacillus plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells. BMC Microbiology 2013; 13(1) doi: 10.1186/1471-2180-13-190
204
Dominika Winiarz, Kamila Domańska, Kinga Paluch, Dorota Dorota Skrajnowska. PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO. Prospects in Pharmaceutical Sciences 2017; 15(10): 86 doi: 10.56782/pps.82
205
J.R. Endres, I. Qureshi, T. Farber, J. Hauswirth, G. Hirka, I. Pasics, A.G. Schauss. One-year chronic oral toxicity with combined reproduction toxicity study of a novel probiotic, Bacillus coagulans, as a food ingredient. Food and Chemical Toxicology 2011; 49(5): 1174 doi: 10.1016/j.fct.2011.02.012
206
Zaigham Abbas, Javed Yakoob, Wasim Jafri, Zubair Ahmad, Zahid Azam, Muhammad W. Usman, Sara Shamim, Muhammad Islam. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2014; 26(6): 630 doi: 10.1097/MEG.0000000000000094
207
Beom Jae Lee, Young-Tae Bak. Irritable Bowel Syndrome, Gut Microbiota and Probiotics. Journal of Neurogastroenterology and Motility 2011; 17(3): 252 doi: 10.5056/jnm.2011.17.3.252
208
Geoffrey A. Preidis, Bruno P. Chumpitazi, Robert J. Shulman. Pediatric Neurogastroenterology. 2017; : 53 doi: 10.1007/978-3-319-43268-7_5
209
Keren Hod, Yehuda Ringel. Probiotics in functional bowel disorders. Best Practice & Research Clinical Gastroenterology 2016; 30(1): 89 doi: 10.1016/j.bpg.2016.01.003
210
K. Hod, Y. Ringel. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 355 doi: 10.1016/B978-0-12-804024-9.00038-0
211
Stephen M Vindigni, Elizabeth K Broussard, Christina M Surawicz. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics forClostridium difficileand beyond. Expert Review of Gastroenterology & Hepatology 2013; 7(7): 615 doi: 10.1586/17474124.2013.832501
212
Nancy Toedter Williams. Probiotics. American Journal of Health-System Pharmacy 2010; 67(6): 449 doi: 10.2146/ajhp090168
213
Hamish Philpott, Sanjay Nandurkar, John Lubel, Peter R Gibson. Alternative investigations for irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2013; 28(1): 73 doi: 10.1111/j.1440-1746.2012.07291.x
214
Julia König, Ignacio Rangel, Robert J. Brummer. The Role of Lactic Acid Bacteria in the Pathophysiology and Treatment of Irritable Bowel Syndrome (IBS). Food and Nutrition Sciences 2013; 4(11): 27 doi: 10.4236/fns.2013.411A005
215
Richard Glickman-Simon, Indranill Basu Ray. Acupuncture, Lactobacillus Traditional Chinese Herbal Medicine, Sanchitongtshu, and Honey. EXPLORE 2012; 8(5): 310 doi: 10.1016/j.explore.2012.06.009
216
Juan José Sebastián Domingo. Revisión del papel de los probióticos en la patología gastrointestinal del adulto. Gastroenterología y Hepatología 2017; 40(6): 417 doi: 10.1016/j.gastrohep.2016.12.003
217
Kajal Farahmandi, Sadegh Sulaimany. Advances in Probiotics for Health and Nutrition [Working Title]. 2023;  doi: 10.5772/intechopen.109717
218
M.J. Hosseini ., R. Ranjbar ., H. Ghasemi ., H.R. Jalalian .. The Prevalence and Antibiotic Resistance of Shigella sp. Recovered from Patients Admitted to Bouali Hospital, Tehran, Iran During 1999-2001. Pakistan Journal of Biological Sciences 2007; 10(16): 2778 doi: 10.3923/pjbs.2007.2778.2780
219
Mariana Buranelo Egea, Josemar Gonçalves de Oliveira Filho, Ailton Cesar Lemes. Investigating the Efficacy of Saccharomyces boulardii in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far. International Journal of Molecular Sciences 2023; 24(15): 12015 doi: 10.3390/ijms241512015
220
Bo Søndergaard, Johan Olsson, Kajsa Ohlson, Ulla Svensson, Peter Bytzer, Rickard Ekesbo. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial. Scandinavian Journal of Gastroenterology 2011; 46(6): 663 doi: 10.3109/00365521.2011.565066
221
Devaraja Gayathri, Alurappa Ramesha. Gluten‑hydrolyzing probiotics: An emerging therapy for patients with celiac disease (Review). World Academy of Sciences Journal 2020;  doi: 10.3892/wasj.2020.55
222
M. SIMRÉN, L. ÖHMAN, J. OLSSON, U. SVENSSON, K. OHLSON, I. POSSERUD, H. STRID. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double‐blind, controlled study. Alimentary Pharmacology & Therapeutics 2010; 31(2): 218 doi: 10.1111/j.1365-2036.2009.04183.x
223
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council 2020; (5): 104 doi: 10.21518/2079-701X-2020-5-104-112
224
Rebecca Taylor. What are functional foods and what they can do?. Nursing and Residential Care 2011; 13(2): 72 doi: 10.12968/nrec.2011.13.2.72
225
Natalia Pedersen, Nynne Nyboe Andersen, Zsuzsanna V&eacute;gh, Lisbeth Jensen, Dorit Vedel Ankersen, Maria Felding, Mette Hestetun Simonsen, Johan Burisch, Pia Munkholm. Ehealth: Low FODMAP diet <italic>vs Lactobacillus rhamnosus</italic> GG in irritable bowel syndrome. World Journal of Gastroenterology 2014; 20(43): 16215-16226 doi: 10.3748/wjg.v20.i43.16215
226
Hannah Claire Baker, Dang Ngoc Tran, Linda Valerie Thomas. Health benefits of probiotics for the elderly: a review. Journal of Foodservice 2009; 20(5): 250 doi: 10.1111/j.1748-0159.2009.00147.x
227
Leonilde Bonfrate, Jan Tack, Ignazio Grattagliano, Rosario Cuomo, Piero Portincasa. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scandinavian Journal of Gastroenterology 2013; 48(9): 995 doi: 10.3109/00365521.2013.799220
228
Fredrick Asare, Stine Störsrud, Magnus Simrén. Meditation over Medication for Irritable Bowel Syndrome? On Exercise and Alternative Treatments for Irritable Bowel Syndrome. Current Gastroenterology Reports 2012; 14(4): 283 doi: 10.1007/s11894-012-0268-2
229
Ahmed E. Salem, Rajdeep Singh, Younan K. Ayoub, Ahmed M. Khairy, Gerard E. Mullin. The gut microbiome and irritable bowel syndrome: State of art review. Arab Journal of Gastroenterology 2018; 19(3): 136 doi: 10.1016/j.ajg.2018.02.008
230
Wai-Yee Fung, Huey-Shi Lye, Ting-Jin Lim, Chiu-Yin Kuan, Min-Tze Liong. Probiotics. Microbiology Monographs 2011; 21: 139 doi: 10.1007/978-3-642-20838-6_6
231
Lynne V McFarland. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 2014; 4(8): e005047 doi: 10.1136/bmjopen-2014-005047
232
Fariba Tarhani, Alireza Nezami. Role of probiotics in treatment of congenital heart disease and necrotizing enterocolitis. PharmaNutrition 2019; 8: 100144 doi: 10.1016/j.phanu.2019.100144
233
Julia König, Robert-Jan Brummer. Pharma-Nutrition. AAPS Advances in the Pharmaceutical Sciences Series 2014; 12: 55 doi: 10.1007/978-3-319-06151-1_4
234
K. Nobutani, D. Sawada, S. Fujiwara, Y. Kuwano, K. Nishida, J. Nakayama, H. Kutsumi, T. Azuma, K. Rokutan. The effects of administration of theLactobacillus gasseristrain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome. Journal of Applied Microbiology 2017; 122(1): 212 doi: 10.1111/jam.13329
235
Theodoros Kelesidis, Charalabos Pothoulakis. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therapeutic Advances in Gastroenterology 2012; 5(2): 111 doi: 10.1177/1756283X11428502
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345